Last updated: November 28, 2024
Sponsor: Sohag University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Dysfunctional Uterine Bleeding
Thrombosis
Thrombocytopenia And Thrombocytopenia Prevention
Treatment
Acute phase proteins
Clinical Study ID
NCT06715215
Soh-Med-24-11-13MS
Ages 1-50 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients with platelet less than 100 × 109/L diagnosed as immune thrombocytopenia bybone marrow findings .
Age of patients : from 1 year to 50 years.
Exclusion
Exclusion Criteria:
Other causes of thrombocytopenia as:
Hypersplenism.
Bone marrow diseases including : aplastic anemia, leukemia and myelodysplasticsyndromes.
Cancer treatments like chemotherapy and radiation therapy.
Exposure to toxic chemicals as arsenic and benzene.
Medications to treat bacterial infections (antibiotics)and treat seizures orblood thinner heparin.
Study Design
Total Participants: 100
Treatment Group(s): 1
Primary Treatment: Acute phase proteins
Phase:
Study Start date:
November 15, 2024
Estimated Completion Date:
December 30, 2026
Connect with a study center
Sohag university hospital
Sohag, Sahag
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.